Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Control of Aging and Disease - the MetAGE Deep Phenotyping Cohort (Pro-Metage)

NCT06511297 is registered in ClinicalTrials.gov with Thomas Scherer as lead sponsor.

NCT NCT06511297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06511297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Control of Aging and Disease - the MetAGE Deep Phenotyping Cohort (Pro-Metage)
Lead sponsor
Thomas Scherer
Phase
Observational
Overall status
Recruiting
Start date
May 5, 2025
Completion date
January 1, 2036
Enrollment
650 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aging, aging problems, metabolic syndrome, obesity